NDC 14803-503-00 - Labetalol Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 14803-503
- Requested NDC
- 14803-503-00
- Package NDCs from labels
- 14803-503-00
- Manufacturer
- ELYSIUM PHARMACEUTICALS LIMITED
- Effective date
- 2019-04-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Labetalol Hydrochloride - ELYSIUM PHARMACEUTICALS LIMITED | ELYSIUM PHARMACEUTICALS LIMITED | 2019-04-17 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | REMEDYREPACK INC. | ae5d7b3b-e444-48d3-9d85-9b07319f9374 | 2026-04-10 | Warnings, Adverse reactions | 1GEV3BAW9J |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | Advagen Pharma Ltd | 106a0959-5830-489f-ba60-afd4eb0fac36 | 2026-04-02 | Warnings, Adverse reactions | 1GEV3BAW9J |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | Advagen Pharma Ltd | 1c680447-b43a-4ff1-bc64-2c2174ca1c9a | 2026-04-02 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | d4364caf-46c6-4144-9ba5-2c561e4f3a95 | 2026-03-26 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | d207396a-068e-4229-88cc-a1a4df7aeff2 | 2026-03-07 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | b4a5f170-a400-4986-8c64-f55d0413f0f6 | 2026-03-07 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | bf84ebae-3c91-4448-b1db-8e5ed3053866 | 2026-03-05 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Major Pharmaceuticals | 35b5fd32-581d-427b-9a13-b7a02846d21d | 2026-03-03 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Civica, Inc. | d7c53b1c-b6a5-482a-a7c8-7425d9cd9ef8 | 2026-03-03 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Zydus Pharmaceuticals USA Inc. | 5942a5a8-c3c1-4ecb-921e-9bc92393bdf8 | 2026-03-02 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Unichem Pharmaceuticals (USA), Inc. | ed0188ba-3fd3-4680-a829-ba242a115fab | 2026-02-25 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Biocon Pharma Inc. | 27e4ab03-c17b-4268-912c-e45a5e8f8dd8 | 2026-02-19 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Northwind Health Company, LLC | faf7a1ff-f18a-8ca7-e053-6394a90a1b1f | 2026-01-01 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Innogenix, Inc. | 82fc2d64-0572-4a9b-94fc-f6eb8d930c54 | 2025-12-23 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 99a715a0-4579-410c-b102-7ef6fab8db55 | 2025-12-19 | Warnings, Adverse reactions | 1GEV3BAW9J |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | Redpharm Drug | 32525ed4-3cca-2b99-e063-6294a90a6c66 | 2025-12-13 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Chartwell RX, LLC | ac439c08-1e47-4306-8308-b31d7a1a443c | 2025-12-02 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Mullan Pharmaceutical Inc. | fb5ef3ba-0a7e-4f41-9547-d734983da0d3 | 2025-12-01 | Warnings, Adverse reactions | 1GEV3BAW9J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.